Back to News
Liquid AI's LFM2 Beats GPT-5 and Claude on Aging Research Tasks
Liquid AI and Insilico Medicine released two small LFM2 variants that beat GPT-5, Gemini-3.1-Pro, and Claude Opus on aging biology benchmarks.
Source
Liquid AI
Published
Author
AlphaSignal Newsroom
Read
1 min read
Liquid AI and Insilico Medicine released two small LFM2 variants that beat GPT-5, Gemini-3.1-Pro, and Claude Opus on aging biology benchmarks.
Reporting is indexed from AlphaSignal. Rights remain with the original publisher and cited sources.
Read original report
